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Abstract 
The current gold standard for nasal reconstruction after rhinectomy or severe trauma includes 
transposition of autologous cartilage grafts in conjunction with coverage using an autologous skin 
flap. Harvesting autologous cartilage requires a major additional procedure that may create donor 
site morbidity. Major nasal reconstruction also requires sculpting autologous cartilages to form a 
cartilage framework, which is complex, highly skill-demanding and very time consuming. These 
limitations have prompted facial reconstructive surgeons to explore different techniques such as 
tissue engineered cartilage. This work explores the use of multi-material 3D bioprinting with 
chondrocyte-laden gelatin methacrylate (GelMA) and polycaprolactone (PCL) to fabricate constructs 
that can potentially be used for nasal reconstruction. In this study, we have investigated the effect of 
3D manufacturing parameters including temperature, needle gauge, UV exposure time, and cell 
carrier formulation (GelMA) on the viability and functionality of chondrocytes in bioprinted constructs.  
Furthermore, we printed chondrocyte-laden GelMA and PCL into composite constructs to combine 
biological and mechanical properties.  It was found that 20% w/v GelMA was the best concentration 
for the 3D bioprinting of the chondrocytes without comprising the scaffold’s porous structure and cell 
functionality. In addition, the 3D bioprinted constructs showed neocartilage formation and similar 
mechanical properties to nasal alar cartilage after a 50-day culture period. Neocartilage formation 
was also observed in the composite constructs evidenced by the presence of glycosaminoglycans 
and collagen type II. This study shows the feasibility of manufacturing neocartilage using 
chondrocytes/GelMA/PCL 3D bioprinted porous constructs which could be applied as a method for 
fabricating implants for nose reconstruction.  
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1. Introduction 
3D printing can potentially benefit plastic and reconstructive surgeries by fabricating patient-specific 
tissue replacements with tissue-like functions and mechanical properties. One specific example in 
the field of plastic and reconstructive surgery is nasal reconstruction. The nose is the most 
identifiable feature that defines the human face. Deformities caused by trauma, cancer surgery and 
malformations can have adverse physical and psychological effects on the patients [1]. The nose is 
comprised of hyaline cartilage, fibro-fatty tissues, internal nasal lining and skin [2]. The current 
surgical approach for major nose reconstruction is a complex and time-consuming procedure that 
involves harvesting rib cartilage, and manually carving and suturing them into a nose-shaped 
framework. Shaping harvested rib cartilage into a nose-shaped framework is highly skill demanding, 
which requires prolonged training to perfect. Once completed the framework is then covered by 
autologous skin and mucosa inner nasal lining [3]. Due to the complexity of the surgical procedure, 
the duration of the operation can exceed 8 hours, during which time the patient is under general 
anaesthesia [4]. In addition, harvesting large amounts of rib cartilage is associated with postoperative 
chest wall deformities, high levels of postoperative pain and the risk of iatrogenic pneumothorax. 
These drawbacks of the current approach for major nasal reconstruction fuelled the interests from 
facial plastic and reconstructive surgeons in finding tissue engineered nasal replacements.  
Since the seminal work on tissue engineered ear-shaped cartilage using polymer scaffolds seeded 
with chondrocytes [5], a body of work has been carried out to fabricate a tissue engineered ear [6],[7] 
or nose [8]. A recent first-in-man trial has utilised autologous chondrocyte-seeded collagen sheet for 
repairing the nose alar lobule after excision of non-melanoma skin cancer. The results from this 
study showed that the tissue engineered constructs formed fibrocartilage in vitro and generated 
satisfactory functional outcomes after one-year implantation, despite the fact that the fibrocartilage 
was remodelled into fibromuscular fatty tissues [9]. This is a very encouraging advancement towards 
the use of tissue engineered constructs in nose reconstruction. However, the mechanical properties 
of the engineered nasal tissue need to be increased in order to use them in major nasal 
reconstructions. 
3D bioprinting is emerging as an alternative approach for fabricating patient-specific nose/ear 
constructs suitable for implantation. Compared to conventional scaffold fabrication methods, 3D 
bioprinting can fabricate patient-specific scaffolds/constructs with controlled architectures without 
moulding. In addition, cells can be printed within the scaffolds/constructs with much better spatial 
precision compared to cell seeding into porous scaffolds. Nose-shaped hydrogel constructs have 
been made using bioprinting of chondrocyte-laden alginate/gellan. The study showed high shape 
fidelity of the bioprinted constructs, and the secretion of cartilage-related matrices during in vitro 
cultivation. One limitation was that the cells within the central region of constructs showed reduced 
viability due to insufficient mass transportation.  In addition, the mechanical strength of the hydrogel 
was lower than septal cartilage due to the inherent low mechanical properties of hydrogels [10]. 
Another study has employed a multi-material approach to improve mechanical stability and the 
transportation of nutrients and oxygen. In this approach materials that promote cartilage regeneration 
and offer mechanical support, respectively, were combined to form 3D composite structures. The 
composite structure consisted of a cell-laden blend hydrogel containing gelatin, fibrinogen, 
hyaluronic acid and glycerol which was co-printed with PCL and Pluronic F-127 to form an ear-
shaped construct. Micro channels were incorporated within the structure in order to enhance 
nutrients and oxygen transport [11]. After crosslinking of fibrinogen using thrombin post printing, the 
uncrosslinked components (gelatin, HA, glycerol and Pluronic F-127) were removed. Although the 
work was a significant advance in bioprinting tissues with clinically relevant sizes, the hydrogel blend 
was complex, which may hinder its clinical translation. The employment of a hydrogel that crosslinks 
during printing and does not need any sacrificial material will reduce fabrication time and the 
complexity of the final constructs, hence a significant advance for the translation of bioprinted tissues 
to the clinic.  
The promising multi-material bioprinting approach [12–14]  has encouraged us to fabricate nose-
shaped cartilaginous constructs for nasal reconstruction. In our previous work we have demonstrated 
the ability to create personalised 3D nose-shaped scaffolds with controlled surface porosity using 
PCL [15]. Following this work, here we investigated the multi-material 3D bioprinting with PCL and 
chondrocyte-laden GelMA for fabricating nasal cartilage. We used the hydrogel GelMA as a cell 
carrier, due to its desirable characteristics such as biocompatibility [16], biodegradability [17], limited 
antigenicity [18] and fast crosslinking using UV light. A multi-material printing process with acellular 
GelMA/Hyaluronic acid and PCL has been previously reported by Schuurman et al [19]. In that study 
PCL was used simply as a mould to confine the GelMA/Hyaluronic acid mixture in place. Hyaluronic 
acid was used to increase the viscosity of GelMA to make it printable. The difference of our work is 
that the thermo-responsive property of GelMA is utilised to increase viscosity, facilitate printability 
and create self-supporting strands without the need of adding excipients or supportive moulds. 
Additionally, the use of GelMA allowed the incorporation of interconnected pores within the structure. 
PCL was used to give structural support and mechanical stability to the entire construct. Our 
approach simplifies the material system, hence benefiting the subsequent clinical translation of the 
bioprinted tissues.  
Here, we first evaluated the effect of the 3D printing process parameters including printing 
temperature, needle gauge and UV exposure on the viability and genotoxicity of chondrocytes. 
Subsequently, cell proliferation, cartilage ECM secretion and mechanical properties of the 3D 
bioprinted porous cell-laden GelMA were quantified. Lastly, cell-laden GelMA/PCL porous constructs 
were bioprinted and their in vitro performance was studied for 21 days. Collectively, the results have 
demonstrated the proof of concept of employing multi-material bioprinting to fabricate tissue 
replacements for nasal reconstructive surgeries. 
 
2. Materials and methods 
 
2.1.  Preparation of GelMA 
GelMA was prepared as previously described by Van Den Bulcke et al [16]. Briefly, a 10% gelatin 
solution (skin porcine gelatin type A G2500, Sigma-Aldrich) was prepared in phosphate buffer saline 
( 0.01M P4417, Sigma-Aldrich) at 50 °C. After an hour, 8 ml of methacrylic anhydride (276685 Sigma-
Aldrich) was added dropwise at a speed of 0.5 ml/min to the gelatin solution and allowed to react for 
3 hours at 50°C. To stop the reaction, the solution was diluted 5X with warm phosphate buffer 
solution (PBS). In order to remove any unreacted methacrylic anhydride, the mixture was dialysed 
against distilled water using 80 kDa dialysis membranes for 1 week. The final solution was freeze-
dried for 7 days and stored at -80 °C.  
 
2.2.  Rheological testing 
GelMA 10%, 15% and 20% solutions were prepared by dissolving the required amount of polymer 
in α-MEM (12-169F, Lonza). After GelMA was fully dissolved, the photo initiator Irgacure 2959 was 
added at a concentration of 0.5% w/v.  
Rheological evaluation was performed on a MCR rheometer (Anton-Paar). To evaluate the viscosity 
of different concentrations of GelMA a 25 mm diameter parallel plate was used with a gap of 0.5 mm. 
The viscosity was measure at each temperature while the gels were subjected to a temperature 
decrease ramp in the range of 37-15ᵒC with a decrease rate of 5ᵒC/min at a constant shear rate of 
100 (1/s). All measurements were conducted in triplicates. To determine the time needed to crosslink 
GelMA, 200 µl of the different GelMA concentrations were added on the rheometer and exposed to 
UV light for a range of time from 10-30 seconds using the UV lamp Omnicure Series 1000 (Lumen 
Dynamics). The complex modulus was measured after UV crosslinking using an 8 mm diameter 
plate at a frequency of 1 Hz. 
 
2.3.  Chondrocytes isolation and expansion 
Cartilage tissue was harvested from sheep condyle. The cartilage was shaved from the condyle 
using a scalpel and immersed in PBS containing 5% antibiotics/antimycotics. The cartilage slices 
were then washed three times with the same solution in order to remove any remaining blood. 
Afterwards, the slices were cut into 2 mm2 pieces. Chondrocytes were isolated through an enzymatic 
digestion by immersing the cartilage pieces in an α-MEM (12-169F, Lonza) solution containing 0.2% 
collagenase type II (234155, Sigma-Aldrich) for 4 hours. After the cartilage pieces were completely 
digested, the solution was passed through a 70 µm nylon strainer and centrifuged at 700 x g for 5 
minutes. Isolated cells were plated in T75 flasks and cultured with α-MEM (12-169F, Lonza) 
supplemented with 5% (v/v) foetal calf serum, 1% MEM non-essential amino acids solution (M7145, 
Sigma-Aldrich), 1% antibiotics/antimycotics, 1% L-glutamine (25030081, Gibco) 0.025 g/ml of 
ascorbic acid (A92902, Sigma-Aldrich), 10 ng/mL TGF-β-1 (T7039, Scientific laboratories supplies 
Ltd) and 5 ng/mL FGF-2 (SRP4037, Sigma-Aldrich).  Cells passage 1 were used for viability studies 
and 3D bioprinting experiments. 
 
2.4.  Viability and genotoxicity studies 
Cell viability was assessed separately on each step of the printing process. All the viability studies 
were performed n=5. The assessment was performed using LIVE/DEAD cell viability assay (L3224, 
Thermo Fisher Scientific) following the manufacturer’s instructions. In brief, 4 μM calcein-AM and 8 
μM ethidium homodimer-1 (EthD-1) were prepared in media and added to the cell-laden print 
constructs and incubated at 37°C for 1 h. Live cells stained by calcein-AM were imaged as green, 
and dead cells stained by EthD-1 were imaged as red using a fluorescence microscope. LIVE/DEAD 
and microscopy were selected for the analysis of cell viability because they are not dependant on 
the diffusion of reactants out of  the hydrogel for quantification. The number of green/red cells were 
quantified using a fluorescence microscope and the ImageJ software. For the evaluation of the cells 
encapsulated inside the hydrogel, six different planes in the z direction were imaged and quantified. 
Cell proliferation was evaluated by DNA quantification. The cells were released from the gels by 
papain digestion overnight. DNA was quantified using Quant-iT™ PicoGreen® dsDNA Assay Kit 
(P7589, Thermo Fisher Scientific) according to the manufacturer instructions.  
Genotoxicity of UV cells was evaluated based on a previous study [20]. Briefly, chondrocytes were 
seeded at a density of 10 X 105 cells/well, exposed and to UV light for 10, 60, 150 and 600 seconds 
with Omnicure s1000 lamp at 2% power. After exposition, the cells were incubated for 24 hours at 
37°C and 5% CO2. Media was removed and cells were washed with PBS before fixing them with 1% 
paraformaldehyde at 0°C for 15 minutes. Following fixation, cells were immersed in 70% ethanol for 
20 hours at -20°C. Then, cells were washed twice in PBS and immersed in 0.2% Triton-X-100/PBS 
1% for 30 minutes. Cells were incubated overnight in 1% BSA containing 5 µg/ml mouse anti-
vertebrates phosphor-histone monoclonal antibody Ser139 (05636, Merck Millipore, UK) at 4°C. This 
was followed by another wash with PBS and incubation with Alexa Fluor 488 goat anti-mouse IgG 
conjugated secondary antibody (1:200) (ab150113, Abcam) for 30 minutes at room temperature. 
Finally, cells were co-stained with Hoechst 33258 1µ/ml (861495, Sigma-Aldrich) for 15 minutes. 
Samples were imaged under the fluorescent microscope (Leica DM IRB).  
 
2.5.  3D printing and cell culture of GelMA/chondrocytes constructs  
GelMA 10%, 15% and 20% hydrogels were prepared by dissolving the required amount of polymer 
in α-MEM). After GelMA was fully dissolved, the photo initiator Irgacure 2959 was added at a 
concentration of 0.5% w/v. The polymer solutions were briefly vortexed and sterile filtered before 
use. 
Passage 1 chondrocytes were detached using trypsin EDTA, centrifuged at 700 x g for 5 min and 
resuspended in GelMA at a concentration of 10 X 106 cells/ml. The solution was transferred to the 
printing cartridge and gel at 20°C in the cooling chamber for 10 minutes. The scaffolds were designed 
in a square shape with overall dimensions of 5 mm X 5 mm. GelMA/chondrocytes were printed at a 
speed of 10 mm/s using the REGENHU 3D Discovery Bioprinter. The spacing between the strands 
was 400 µm and samples were printed using a tapered needle G27. Samples were cross linked for 
20 seconds under UV and transferred to well plates containing α-MEM (12-169F, Lonza) 
supplemented with 5% (v/v) foetal calf serum, 1% MEM non-essential amino acids solution (M7145, 
Sigma-Aldrich), 1% antibiotics/antimycotics, 1% L-glutamine (25030081, Gibco), 0.025 g/ml of 
ascorbic acid (A92902, Sigma-Aldrich), 10 ng/mL TGF-β-1 (T7039, Scientific laboratories supplies 
Ltd) and 5ng/mL FGF-2 (SRP4037, Sigma-Aldrich). Triplicates of samples were printed for each time 
point for the biochemical, histological and mechanical studies. Samples were cultured in dynamic 
conditions using an orbital shaker and medium was changed twice a week. 
 
2.6.  Biochemical assays 
Samples were digested overnight in papain solution (L-cysteine 0.042 mg/ml, PBS, papain 25 µg/ml, 
EDTA 0.005 M) at 60°C. Total DNA was quantified on the papain digests using a Picogreen DNA 
assay (Invitrogen) according to the manufacturer's instructions. Total Glycosaminoglycans (GAGs) 
content was determined by photo spectrometry at 520 nm after the reaction with dimethylmethylene 
blue using a microplate reader (Tecan). GAG content was quantified using chondroitin sulphate 
(Sigma-Aldrich) as a standard. Calculated concentrations in each digested sample were expressed 
as GAGs/DNA. All the studies were performed in triplicates.  
 
2.7. Histological analysis 
Samples were fixed in 7% paraformaldehyde, washed three times with PBS and immersed in 15% 
sucrose for 24 hours and 30% sucrose for 12 hours. Afterwards, the samples were embedded in 
OCT and snap frozen using liquid nitrogen. Samples were cryo sectioned into 10 µm slices and 
stained with fast green (F7552, Sigma-Aldrich) and Safranin-O (HT90432, Sigma-Aldrich) dyes to 
identify the presence of GAGs. The stained sections were examined using a light microscope (Leica 
DM IRB).  
Cryo sectioned samples were also stained with immunohistochemistry for detection of collagen II. 
All sections were permeabilised using 0.1 % Triton X in PBS and blocked with 3% donkey serum 
albumin (D9663, Sigma-Aldrich). Next, sections were incubated with the primary antibodies for 
collagen type II (ab34712 rabbit anti-collagen type II antibody, ab34712, Abcam) at 4 °C overnight. 
Subsequently, sections were incubated with the secondary antibody Alexa Fluor 488 (ab150073 
Donkey anti-rabbit IgG, Abcam) at room temperature for two hours. Finally, sections were co-stained 
with Hoechst 33258 1µ/ml (Sigma-Aldrich) for 15 minutes. Samples were imaged under the 
fluorescent microscope (Leica DM IRB). 
 
2.8. Mechanical testing 
Compression testing was conducted on the samples using TA HD plus texture analyser (Stable micro 
systems). Each specimen was compressed at a displacement rate of 1 mm/min to a maximum force 
of 5 kg. All tests were performed in triplicates. Young’s modulus (MPa) was calculated from the 
stress–strain curve as the slope of the initial linear portion of the curve (5%-10%), with any toe region 
due to the initial settling of the specimen neglected. 
 
2.9.  3D co-printing and culture of PCL/GelMA/chondrocytes constructs  
GelMA/chondrocytes solution was prepared the same way than mentioned previously. Structures 
were designed using newly-developed software integrated into an Excel spreadsheet (‘Scaffold 
Designer’ supplied as supplementary information). Scaffolds were designed with the overall 
dimensions 2 cm X 2 cm X 2 mm. PCL pellets (Mn= 40 000–50 000 g mol−1 Sigma-Aldrich, UK) 
were extruded at a temperature of 77°C at a rate of 16 mm/s PCL strands were printed 2 mm apart 
and GelMA was printed in the central part in between the two PCL strands. One layer of GelMA was 
printed every two repeated layers of PCL. The number of repeated layers refers to the number of 
consecutive layers with the same printing path (Figure 7A). A total of 8 layers of PCL and 4 layers of 
GelMA were printed. GelMA was cross linked for 20 seconds after deposition.  
 
2.10.     Statistical analysis 
Statistical analysis was performed using Prism version 8.0 (GraphPad Software, USA). Statistical 
significance was determined by two-way ANOVA followed by uncorrected Fisher's least square 
difference multiple-comparison post hoc test. Plots are means with error bars indicating the standard 
error. Statistically significant values are presented as *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 
0.0001. 
 
3. Results and Discussion 
3.1.  GelMA rheological properties 
The rheological properties of hydrogels are one of the most important parameters which determine 
their printability [21]. Printability for a bioink can be determined by the ease with which it could be 
printed with good resolution and maintenance of its structure after printing [22]. Previously, a 
viscosity range of 1 to 10 Pa·s (at shear rate of 100 1/s) for hydrogels has been demonstrated to be 
suitable for 3D extrusion-based bioprinting [23]. In order to identify a suitable concentration and 
temperature for bioprinting GelMA, a rheological study was performed. Viscosities of 10%, 15% and 
20% GelMA were measured as a function of temperature. As shown in Figure 1A, it was observed 
that the viscosity of GelMA is temperature and concentration dependant. To achieve viscosities 
within the range of 1- 10 Pa-s different temperatures were required for the three different GelMA 
concentrations.  As temperatures lower than 15°C could be detrimental for the cells viability [24], a 
printability temperature window was set from 15°C to 37°C.   As observed in Figure 1 only 15% and 
20% GelMA hydrogels fit into this printability window. Based on the rheological results, 15°C and 
20°C were selected as the printing temperatures for 15% and 20% GelMA respectively. The 
viscosities at these temperatures are comparable to the viscosity of 10% printable GelMA 
supplemented with gellan gum [25].  
Due to the photo crosslinkable property of GelMA, once the strand is printed it can be immediately 
UV crosslinked. The immediate crosslinking allows the strand to preserve its structure and support 
itself without the need of temperature control. The minimal UV dosage necessary to crosslink GelMA 
and increase its complex modulus was investigated in this section. Different concentrations of GelMA 
were exposed to UV for 10, 20 and 30 seconds and the complex modulus was measured using a 
rheometer. Figure 1B shows the increase in the complex modulus with the increase of UV exposure. 
After 10 seconds of exposure, an average of 10-fold increase was observed for all concentrations 
compared with the non-exposed samples. A 10.5, 30.5 and 59.5-fold increase was observed after 
20 seconds and a 40, 58 and 85-fold increase after 30 seconds for 10%, 15% and 20% GelMA 
respectively. Twenty seconds was chosen as the crosslinking time because is the minimum 
crosslinking time where a difference in modulus can be observed between the three concentrations. 
 
 
Figure 1.  Rheological properties of GelMA hydrogels of different concentrations. A) Viscosity of 
three different concentrations of GelMA (10%, 15% and 20%) as a function of temperature. The 
viscosities were measured at a shear rate of 100 s-1. Black rectangular box represents the viscosity 
range of 1-10 Pa·s. B) Complex moduli of 10%, 15% and 20% GelMA after UV exposure for 0, 10, 
20 and 30 seconds at an UV intensity of 31 mW/cm2. 
 
3.2. Effects of the 3D printing process on chondrocytes viability and genotoxicity 
Different variables can affect cell viability during extrusion-based bioprinting processes [22]. The 
ones considered in this study were the concentration of GelMA, needle gauge, printing temperature, 
printing time and the UV exposure for crosslinking. All these parameters were studied individually in 
order to determine their effects on cell viability.  
During the printing process the cells have to remain encapsulated in non-crosslinked GelMA for a 
period of up to 2 hours. As part of the viability assessment the first step was to study if the non-
crosslinked material has any cytotoxic effect on the cells. For this reason, the effect of different 
concentrations of GelMA (10%, 20%, 30%) on cell viability was assessed by encapsulating the cells 
within the material for 2 hours at room temperature. The results in Figure 2A show just a 3% 
reduction in viability of the chondrocytes when cultured in GelMA compared with the monolayer 
control. Additionally, it was observed that there was no significant effect on cells viability among the 
tested concentrations, with all of them showing an average of 90% viable cells.  
Other parameters that may influence cell viability include the printing temperature (15°C and 20°C 
for 15% and 20% GelMA) and the time exposed to it. Cells encapsulated in GelMA have to remain 
in a cooled syringe during printing and this time could vary from minutes to approximately 2 hours 
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15°C, 20°C and 37°C were tested for their effect on cell viability with time frames from 15 minutes to 
2 hours. Figure 2B shows that the three different temperatures did not have a significant effect on 
cells viability for the various printing time periods suggesting that the cells can remain viable if these 
temperatures are used in order to increase GelMA viscosity.  
Another parameter we assessed was the needle gauge. The shear stress that the cells experience 
during printing depends on the internal diameter of the needle, dispensing pressure and bioink 
consistency [22]. Some studies have shown that high shear stress can cause cell death [26]. For our 
studies, gauges 27 (203 µm internal diameter (ID)) and 30 (180 µm ID) were chosen because high 
printing resolution (small strand diameter) was desirable. The dispensing pressure was kept constant 
at the lowest (2 bar) that allowed the extrusion of the material. The viability was quantified on day 0 
immediately after printing and on day 3. An average of 80% viable cells was obtained with both 
needle gauges (Figure 2C), which is an acceptable viability and is comparable to previous 
publications [27,28]. Liu and co-workers showed that viabilities of HUVECS encapsulated in GelMA 
and printed with a G27 needle were 85.1% ± 7.0% at day 1 and  89.3% ± 0.6% at day 7 [28]. Similarly, 
Billiet and co-workers showed an average viability of 90% for HepG2 cells encapsulated in GelMA 
and printed with the same needle [27].  Even though both of our needle diameters showed similar 
viability, for the following studies G27 was chosen because G30 required increased dispensing 
pressure for the formation of a uniform strand and nozzle blocking occurred more frequently (data 
not shown).  
As a UV-activatable photoinitiator (Irgacure 2959) was used for crosslinking GelMA, we investigated 
the effect of UV exposure on cell viability and genotoxicity. The UV cytotoxicity and genotoxicity can 
vary depending on the UV dosage which is determined by the UV intensity and the time during which 
the cells are exposed (UV dosage = Intensity mW/cm2 × time (s)) [29].   It was found that 20 seconds 
at an intensity of 31mW/cm2 (UV dosage 0.62 J/cm2) was the minimal dosage needed to crosslink 
GelMA.  We then investigated what was the maximum dose that the cells could tolerate. During the 
printing process cells will be receiving incremental exposure as each subsequent layer requires UV 
crosslinking and the penetration of UV. To study the effect of the UV dosage on the viability and 
genotoxicity, chondrocytes were exposed to UV from 10 seconds to 12 minutes (UV dosages from 
0.31 to 22 J/cm2). Figure 2D shows that there is no significant effect on cells viability when UV 
exposure time varied from 10 seconds to 3 minutes, which agrees with previous work [30],[31],[32]. 
In contrast only 20% of the cells remained viable after 6 minutes (UV dose 11.16 J/cm2) and 0% 
after 12 minutes (UV dose 22.32 J/cm2). These results were comparable to similar studies that 
showed decreased viability of primary chondrocytes after exposed to UV dosages higher than 5 
J/cm2 [33][34].  
 
 
Figure 2. Chondrocytes viability assessment with LIVE/DEAD under different 3D printing parameters 
and UV dosages. The control group were chondrocytes cultured in monolayer on tissue culture 
plastic. A) Viability of chondrocytes encapsulated in a range of different concentrations of GelMA for 
24 h (casted samples).  B) Viability of cells encapsulated in 20% GelMA exposed at 15 °C, 20°C and 
37°C for a period of 15 minutes to 2 hours. C) Viability of chondrocytes encapsulated in 20% GelMA 
after been extruded through two different needle gauges G30 (180 µm internal diameter) and G27 
(210 µm internal diameter) at 18C. No statistical difference was observed between both groups.  D) 
Viability of chondrocytes after different UV exposition times (UV intensity= 31 mW/cm2). Table shows 
the relevant UV dosages. * p < 0.05, ** p < 0.01. The data expressed is the mean number (n=5). 
Error bars represent the standard error.  
 
Studies have shown that UV light causes cell death by damaging the DNA which can affect 
transcription, replication or induce apoptosis [35]. Therefore, even though cells remained viable after 
UV exposure for up to 5.58 J/cm2, it is important to consider the genotoxicity that could induce further 
cell death or changes in genomic stability. This effect was assessed by measuring the expression of 
γ-H2αX, an early detection marker of DNA damage [36]. Cells were exposed to UV from 10 seconds 
to 10 minutes (UV dosages in Figure 3B) and γ-H2ΑX expression was analysed 24 hours after the 
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the total cell number. Figure 3A shows the cells expressing γ-H2ΑX in green and the cell nuclei 
stained with DAPI (blue). Cells exposed to 10 seconds and 1 minute (UV dosage 0.31 and 1.86 
J/cm2) did not expressed any detectable DNA damage while 50% of the cells exposed for 2.5 minutes 
(UV dosage 4.65 J/cm2) were DNA damaged. The damaged cell population increased to 90% after 
exposure for 10 minutes (UV dosage 18.6 J/cm2) (Figure 3B).  
Based on these characterisations, the appropriate printing parameters and UV crosslinking 
conditions were selected for subsequent bioprinting experiments. GelMA concentration of 15% and 
20% was selected because they fit in the printability window when printed at 15 °C and 20 °C 
respectively. The needle gauge 27 (203 µm) was chosen because a lower dispensing pressure can 
be used compared to gauge 30. For this study a maximum of four GelMA layers were printed in order 
to not exceed the limit of genotoxic UV dosage.  
 
Figure 3. Evaluation of genotoxicity on chondrocytes caused by UV exposure. This study was 
performed in cell monolayers in tissue culture plastic. A) Representative images of the chondrocytes 
stained for Ƴ-H2AX expression. The top row shows cells stained with DAPI representing the total 
number of cells and the bottom shows cells stained for Ƴ-H2AX representing DNA double strand 
damage. B) Quantification of the genotoxicity by UV exposure (31 mW/cm2 Intensity) on 
chondrocytes evaluated by the percentage of cells that expressed Ƴ-H2AX. The table converts UV 
exposure time to dosage. **** p < 0.0001. The data expressed is the mean number (n=5). Error bars 
represent the standard error.  
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3.3. In vitro culture of 3D printed chondrocyte-laden GelMA constructs 
The proliferation and ability to produce cartilage ECM of chondrocytes following 3D bioprinting was 
examined in two GelMA concentrations (15% and 20%) for up to 50 days. During cultivation, cell 
proliferation and mechanical properties of the cell-laden constructs were quantified at day 0, 14, 21 
and 50. Gross morphology of the samples, cells distribution, secretion of GAGs and collagen II were 
assessed at the end of the culture period.  
Figure 4A shows representative bright field (top row) and fluorescent images (bottom row) of the 
printed samples on day 0 and day 50 in vitro. In the bottom row the cells were stained with calcein 
in order to observe their distribution within the scaffolds on day 0 and 50. Firstly, it was observed 
that day 0 samples printed with 20% GelMA showed more uniform strands and pores compared to 
15% GelMA due to higher viscosity (Figure 4A). Secondly, the 3D bioprinted GelMA/chondrocytes 
samples were porous and translucent on day 0 of culture, and became opaque with closed pores by 
day 50 (Figure 4A). This change in gross morphology of the structures was due to the cell expansion 
into the pores and the secretion of ECM. It has been found from the images of cryo-sectioned 
chondrocyte-laden GelMA that cells expanded to the pores (Figure 4B). GelMA is represented in 
red in Figure 4B. It was also observed that a higher number of cells were located at the periphery of 
the sample and inside the pores; cells were still present within the GelMA strands but with a lower 
number (Figure 4B). These results suggest that the chondrocytes that migrated to the pores 
proliferated faster in these locations, possibly because they had easier access to nutrients and 
oxygen. This difference in proliferation rate within different parts of a scaffold due to nutrients 
diffusion has been reported previously [37]. Additionally, these results highlight the importance of 




Figure 4. Gross morphologies of 3D bioprinted four-layer constructs with GelMA/chondrocytes. A) 
Top row: bright field images of 3D bioprinted samples at day 0 and day 50 after cultivation; Bottom 
row: fluorescence images of cells stained with calcein AM on day 0 and day 50 showing the overall 
cell distribution. Scale bars represent 2mm. B) Cryo sections of GelMA/chondrocytes constructs 
stained with DAPI (blue) representing cell distribution at day 50. GelMA distribution is represented 
in red (auto florescence). Areas in white boxes are magnified in images on the right.  
 
 
Proliferation of the cells was quantified at different time points of the culture period based on DNA 










































After day 14 no proliferation was detected in either of the gels. This was expected because primary 
chondrocytes tend to stop proliferating and senesce after serval weeks of in vitro culture [38]. 
Evaluation of the ECM synthesised by the chondrocytes was done by quantifying the amount of 
secreted GAGs, histological staining of GAGs and staining of collagen type II using 
Immunohistochemistry. The amount of GAGs in the samples increased 6 fold from day 0 to 21 of 
culture with no statistically significant difference in the secreted amount between the gels with two 
different concentrations. However, there was no increase of GAGs from day 21 to 50 which could 
be due the high increase in cell density after 21 days (Figure 5B). This effect has been previously 
observed in 3D culture of chondrocytes in alginate beads [39]. Kobayashi et al observed that beads 
with a cell concentration from 1 to 10 x 106 cells/ml showed increase in GAGs secretion during 
culture, but at higher concentrations the secretion was limited. We had an initial concentration of 10 
x 106 cells/ml and it doubled by day 14, which could have affected the rate of GAGs secretion from 
day 14 onwards. Another possible explanation to the cease in GAGs secretion is cartilage tissue 
maturation. It has been previously reported that collagen concentration and pyridinoline cross-link 
concentration increased with maturation, whilst the glycosaminoglycan concentration and 
percentage water content remain unchanged or decrease slightly [40]. This could explain the 
increase in mechanical properties of the samples at day 50 ( Figure 5D). The presence of GAGs at 
day 50 was also confirmed qualitatively by histological staining with Safranin O (Figure 5C). 
Additionally, the presence of collagen II in the GelMA was confirmed using immunohistochemistry at 
day 50 (Figure 5C bottom row).  
The mechanical properties of the engineered tissue are an important factor to consider because the 
tissue has to possess sufficient strength and elasticity to withstand surgical manipulation as well as 
mechanical stresses in situ after implantation to avoid collapse of the reconstructed nose [41]. The 
Young’s moduli of the samples were measured on four different time points by compression testing. 
The young’s modulus of 20% GelMA was approximately twice the value of the 15% GelMA at day 0. 
The moduli of both cell-laden gels increased from day 0 to day 21, and ratio of modulus between the 
20% and the 10% gel decreased slightly. At day 50 the Young’s modulus of 20% and 15% were 4 
and 6 times higher, respectively, compared to day 0 (Figure 5D). This increase at day 50 was 
possibly caused by the maturation of the tissue and increase in collagen content [40]. The modulus 
of 20% cell-laden gels at day 50 (0.8 MPa) was similar to that of lateral nasal cartilage (0.98 MPa) 
but lower than septal cartilage (2.72 MPa) [42]. Due to insufficient mechanical properties of the cell-
laden gels, it is important to add a reinforcement material within the 3D printed structures to increase 
the overall structural mechanical properties. 
 
Figure 5. Proliferation, GAGs secretion and mechanical properties of 3D bioprinted constructs with 
GelMA/chondrocytes during culture. a) Proliferation of chondrocytes quantified by DNA content on 
day 0, 14, 21 and 50. b) GAGs content on day 0, 21 and 50. C) Histological staining of GAGs 
(Safranin O) and collagen II on day 50. GAGs appear orange-red and the cell nuclei appear darker 
red. Cell nuclei were stained by DAPI in blue. Scale bars represent 100 µm. D) Mechanical properties 
measured with compression test of samples at different time points. Young’s modulus (MPa) was 
calculated from the stress–strain curve as the slope of the initial linear portion of the curve (5%-
10%). *p < 0.05. The data expressed in the mean number (n=3). Error bars represent the standard 
error. 
 
3.4.  Multi-material bioprinting and culture of PCL/GelMA/chondrocytes porous constructs 
Polycaprolactone was used as a reinforcement material to create 3D constructs with improved 
mechanical stability. PCL is a FDA approved thermoplastic polymer that has been widely used in 3D 
printing and also has been previously used for structural purposes to print complex structures [12]. 
PCL scaffolds alone with the same porosity have a Young’s modulus of 28.5 Mpa [15]. GelMA  20% 
was used as a cell carrier rather than 15% because of better printing fidelity and there was no 
difference on cell proliferation or ECM secretion between them. Chondrocytes-laden GelMA were 
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diffusion of nutrients and oxygen. The multi-material samples had dimensions of 20 X 20 X 2 mm3 
(Figure 6A). The pores size ranged from 500 to 650 µm (Figure 6C and D). The chondrocytes were 
stained with calcein AM to show their distribution in the final structures (Figure 6D). A compression 
test was performed on GelMA alone and GelMA/PCL samples to identify the difference in mechanical 
properties. Figure 6E shows that the Young’s modulus of the GelMA/PCL samples was 37 times 
higher than that of GelMA. It is worth noting that the Young’s modulus of GelMA/PCL samples was 
similar to PCL alone samples with the same porosity [15]. 
                     
 
Figure 6. Multi-material bioprinting of porous constructs with PCL and GelMA/chondrocytes. A) 
Schematic of the printed structure with PCL (blue) and GelMA (orange). B) A representative image 
of a printed porous construct with 8 layers of PCL and 4 layers of GelMA on the Z direction. Sample 
dimensions are 20 x 20 x 2 mm3.  Scale bar represents 5 mm.  C) Bright field image of the construct 
showing the PCL, GelMA and pores distribution from a top view. Scale bar represents 2 mm. D) A 
fluorescence image indicating chondrocytes (stained with calcein AM) encapsulated in GelMA, pores 
and PCL strands. Scale bar represents 2 mm. E) Young’s modulus of GelMA and GelMA/PCL 


























To study the regeneration of neocartilage tissue in vitro, the samples were cultured for a period of 
21 days and analysed at different time points. A change in GelMA colour was notable, going from 
transparent to white. In addition, the strands gradually spread into the pore space and the width of 
the strands increased from approximately 300 µm to 600 µm after 21 days (Figure 7A), which 
suggested cell proliferation and ECM secretion. Swelling could be another explanation for the 
increase in strand diameter. But previous studies have shown that GelMA 20% has a swelling ratio 
of 10% [43], which means in our case the GelMA strand diameter would be  330 µm rather than 600 
µm. The fluorescence images (Figure 7A) also show that cell-laden GelMA strands filled part of the 
pores by day 21. Proliferation of the cells was confirmed by measuring DNA content (Figure 7B) 
which showed a gradual increase. Cell proliferation seemed to reach a plateau by day 14 of culture, 
similar to what was observed in pure cell-laden GelMA structures. These observations emphasise 
the importance of taking into account the size of the pores during the design of the scaffold to allow 
enough space for cell expansion. Secretion of cartilage related matrix was confirmed by measuring 
the content of GAGs, showing a rapid increase from day 0 to day 7 followed by a more gradual 
increase afterwards (Figure 7C). Collagen II and GAGs were also present confirmed by immuno- 
and histological staining of the cell-laden hydrogel strands (Figure 7D). These results suggest the 
formation of neocartilage in the multi-material cellular scaffolds, similar to the results achieved by 
Kang et al in their in vitro study [11].  However, in order to achieve a full comparison with their multi-
material bioprinted constructs, in vivo studies will need to be carried out in the future on our cellular 
scaffolds.  
                
Figure 7. Bioprinted PCL/GelMA/chondrocytes constructs in culture for 21 days. A) top row: 
representative bright field images of gross change in colour and shape of the samples during a 21-
day culture period. Scale bars represent 1mm. Bottom row: representative fluorescence images of 
chondrocytes (green) distribution. Scale bars represent 2mm. B) Chondrocytes proliferation 
measured by DNA content during 21 days. C) GAGs content during 21 days in culture. D) Histological 
sections of samples on day 21. Left: Immunostaining for collagen II in green and DAPI in blue. Right: 
Safranin O staining of GAGs. Scale bars represent 200 µm. * p < 0.05 ** p < 0.01. Data is expressed 
in the mean number (n=3). Error bars represent the standard error. 
 
In this study 3D printed cell-laden GelMA/PCL porous composite constructs were fabricated by 
































































tissue engineering  and 3D bioprinting, which demonstrated that this material supports chondrocytes 
proliferation, phenotype and ECM secretion[44],[45],[19]. However, a detailed study of the effects of 
the GelMA printing process on cell viability has not been performed. In this work we individually 
evaluated each of the parameters of the 3D printing process with GelMA and their effects on 
chondrocyte viability. We found that the GelMA concentrations from 10% to 30% and temperatures 
ranging from 15C to 37C did not affect cell viability during printing. In contrast, extruding the cells 
through the nozzle reduced the viability by approximately 20%, and prolonged UV exposure 
drastically reduced the viability by 80% after 11.16 J/cm2 UV dosage. It was also found that even 
though viability of the cells was not affected after 5.58 J/cm2 UV dosage, 50% of the cells had DNA 
damage after 4.65 J/cm2 UV dosage, which could lead to mutagenesis of the cells.  
Once that we found the appropriate parameters for printing with GelMA without having detrimental 
effect on the cells, we employed a multi-material approach for the fabrication of the constructs. 
Composite constructs of PCL and chondrocyte-laden GelMA has not been made and characterised 
before. In our study cells were encapsulated in 20% GelMA and co-printed with the PCL strands, 
and channels were created by leaving 650 µm space between the PCL and GelMA strands. The cell 
proliferation and ECM secretion were not affected by the multiple-material printing process when 
compared with the GelMA only structures. This study proves the concept of using a bioprinted 
composite construct that contains chondrocytes, GelMA and PCL for making cartilaginous tissues. 
Future efforts will focus on fabricating constructs with anatomical shapes using this multi-material 
bioprinting approach and cartilage regeneration in animal models. The challenges for printing two 
materials into an anatomic shape mainly lie with the printer’s software ability to define individual 
printing paths for multiple materials and the resolution of the printing (strut diameter). In addition, the 
complexity of an anatomical shape also plays an important role, particularly for extrusion printing 
where a filament is laid down to form shapes. Moreover, the printing resolution (diameter of struts) 
needs to be high (small struts) to allow precise deposition of multiple materials in a nose-shaped 
scaffold which is a thin structure. Currently, the diameter of GelMA struts is in the range of hundreds 
of microns. These challenges will need to be addressed by the combined force of 3D printer 
manufacturers and users in the future. 
 
Conclusions 
This study investigated the feasibility of using multi-material 3D bioprinting to create cell-laden and 
mechanically enhanced constructs that can potentially be used for major nasal reconstruction. The 
hydrogel GelMA was used as a cell carrier and was successfully printed without the need of viscosity 
enhancers or supportive moulds. This was achieved by using the thermo-reversible properties of 
GelMa that showed a suitable viscosity range for extrusion printing at the temperatures of 15°C and 
20°C. A detailed assessment on the effects of 3D printing conditions on the viability and genotoxicity 
of chondrocytes was also performed. This assessment revealed that prolonged UV exposure and 
extrusion had the largest negative effects on cell viability. Based on the rheology data and the cell 
responses during in vitro culture of the bioprinted chondrocyte-laden GelMA constructs, it was found 
that 20% GelMA was the optimal concentration to be used in terms of printability and cell 
functionality. Cell-laden GelMA hydrogels showed cell proliferation and cartilage ECM secretion. 
However, the mechanical properties of the constructs were lower than septal cartilage. Therefore, a 
multi-material approach was adopted to fabricate cell-laden GelMA-PCL porous composite 
structures. This work shows for the first time the printing of porous multi-material GelMA-PCL 
constructs without viscosity enhancers, sacrificial materials or supportive moulds that need removal 
after printing.  The cell proliferation and secretion of cartilage-specific ECM in these composite 
constructs were similar to those in pure cell-laden GelMA constructs, suggesting the combination of 
materials did not interfere with the behaviours of chondrocytes.  
 
Acknowledgments 
We thank CONACYT Mexico for sponsoring the studentship for Laura Ruiz-Cantu. 
 
References 
[1] A. Borges, J. Fink, P. Villablanca, R. Eversole, R. Lufkin, Midline destructive lesions of the 
sinonasal tract: Simplified terminology based on histopathologic criteria, Am. J. Neuroradiol. 
21 (2000) 331–336. doi:10696019. 
[2] J.B. Watelet, P. Van Cauwenberge, Applied anatomy and physiology of the nose and 
paranasal sinuses., Allergy. 54 Suppl 5 (1999) 14–25. 
[3] F.J. Menick, Nasal reconstruction with a forehead flap., Clin. Plast. Surg. 36 (2009) 443–59. 
doi:10.1016/j.cps.2009.02.015. 
[4] S.B. Cannady, T. a Cook, M.K. Wax, The total nasal defect and reconstruction., Facial Plast. 
Surg. Clin. North Am. 17 (2009) 189–201. doi:10.1016/j.fsc.2009.01.002. 
[5] Y. Cao, J.P. Vacanti, K.T. Paige, J. Upton, C.A. Vacanti, Transplantation of Chondrocytes 
Utilizing a Polymer-Cell Construct to Produce Tissue Engineered Cartilage in the Shape of a 
Human Ear, Plast. Reconstr. Surg. (1997) 304–304. 
[6] S.J. Shieh, S. Terada, J.P. Vacanti, Tissue engineering auricular reconstruction: In vitro and 
in vivo studies, Biomaterials. 25 (2004) 1545–1557. doi:10.1016/S0142-9612(03)00501-5. 
[7] N. Isogai, T. Morotomi, S. Hayakawa, H. Munakata, Y. Tabata, Y. Ikada, H. Kamiishi, 
Combined chondrocyte-copolymer implantation with slow release of basic fibroblast growth 
factor for tissue engineering an auricular cartilage construct, J. Biomed. Mater. Res. - Part A. 
74 (2005) 408–418. doi:10.1002/jbm.a.30343. 
[8] S.H. Kamil, K. Kojima, M.P. Vacanti, L.J. Bonassar, C.A. Vacanti, R.D. Eavey, In vitro tissue 
engineering to generate a human-sized auricle and nasal tip, Laryngoscope. 113 (2003) 90–
94. doi:10.1097/00005537-200301000-00017. 
[9] I. Fulco, S. Miot, M.D. Haug, A. Barbero, A. Wixmerten, S. Feliciano, F. Wolf, G. Jundt, A. 
Marsano, J. Farhadi, M. Heberer, M. Jakob, D.J. Schaefer, I. Martin, Engineered autologous 
cartilage tissue for nasal reconstruction after tumour resection: an observational first-in-
human trial., Lancet (London, England). 384 (2014) 337–46. doi:10.1016/S0140-
6736(14)60544-4. 
[10] M. Kesti, C. Eberhardt, G. Pagliccia, D. Kenkel, D. Grande, A. Boss, M. Zenobi-Wong, 
Bioprinting Complex Cartilaginous Structures with Clinically Compliant Biomaterials, Adv. 
Funct. Mater. (2015) 7406–7417. doi:10.1002/adfm.201503423. 
[11] H.-W. Kang, S.J. Lee, I.K. Ko, C. Kengla, J.J. Yoo, A. Atala, A 3D bioprinting system to 
produce human-scale tissue constructs with structural integrity, Nat. Biotechnol. 34 (2016) 
312–319. doi:10.1038/nbt.3413. 
[12] J. Visser, B. Peters, T.J. Burger, J. Boomstra, W.J.A. Dhert, F.P.W. Melchels, J. Malda, 
Biofabrication of multi-material anatomically shaped tissue constructs, Biofabrication. 5 (2013) 
035007. doi:10.1088/1758-5082/5/3/035007. 
[13] J.-H. Shim, J.-S. Lee, J.Y. Kim, D.-W. Cho, Bioprinting of a mechanically enhanced three-
dimensional dual cell-laden construct for osteochondral tissue engineering using a multi-head 
tissue/organ building system, J. Micromechanics Microengineering. 22 (2012) 085014. 
doi:10.1088/0960-1317/22/8/085014. 
[14] F. Pati, J. Jang, D.-H. Ha, S. Won Kim, J.-W. Rhie, J.-H. Shim, D.-H. Kim, D.-W. Cho, Printing 
three-dimensional tissue analogues with decellularized extracellular matrix bioink., Nat. 
Commun. 5 (2014) 3935. doi:10.1038/ncomms4935. 
[15] L. Ruiz-Cantu, A. Gleadall, C. Faris, J. Segal, K. Shakesheff, J. Yang, Characterisation of the 
surface structure of 3D printed scaffolds for cell infiltration and surgical suturing, 
Biofabrication. 8 (2016). doi:10.1088/1758-5090/8/1/015016. 
[16] A.I. Van Den Bulcke, B. Bogdanov, N. De Rooze, E.H. Schacht, M. Cornelissen, H. 
Berghmans, Structural and Rheological Properties of Methacrylamide Modified Gelatin 
Hydrogels, Biomacromolecules. 1 (2000) 31–38. doi:10.1021/bm990017d. 
[17] K. Yue, G. Trujillo-de Santiago, M.M. Alvarez, A. Tamayol, N. Annabi, A. Khademhosseini, 
Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels, 
Biomaterials. 73 (2015) 254–271. doi:10.1016/j.biomaterials.2015.08.045. 
[18] B.J. Klotz, D. Gawlitta, A.J.W.P. Rosenberg, J. Malda, F.P.W. Melchels, Gelatin-Methacryloyl 
Hydrogels: Towards Biofabrication-Based Tissue Repair, Trends Biotechnol. 34 (2016) 394–
407. doi:10.1016/j.tibtech.2016.01.002. 
[19] W. Schuurman, P. a Levett, M.W. Pot, P.R. van Weeren, W.J. a Dhert, D.W. Hutmacher, 
F.P.W. Melchels, T.J. Klein, J. Malda, Gelatin-methacrylamide hydrogels as potential 
biomaterials for fabrication of tissue-engineered cartilage constructs., Macromol. Biosci. 13 
(2013) 551–61. doi:10.1002/mabi.201200471. 
[20] D. Kumar, I. Gerges, M. Tamplenizza, C. Lenardi, N.R. Forsyth, Y. Liu, Three-dimensional 
hypoxic culture of human mesenchymal stem cells encapsulated in a photocurable, 
biodegradable polymer hydrogel: A potential injectable cellular product for nucleus pulposus 
regeneration, Acta Biomater. 10 (2014) 3463–3474. doi:10.1016/j.actbio.2014.04.027. 
[21] T. Billiet, M. Vandenhaute, J. Schelfhout, S. Van Vlierberghe, P. Dubruel, A review of trends 
and limitations in hydrogel-rapid prototyping for tissue engineering., Biomaterials. 33 (2012) 
6020–41. doi:10.1016/j.biomaterials.2012.04.050. 
[22] A. Panwar, L.P. Tan, Current status of bioinks for micro-extrusion-based 3D bioprinting, 
Molecules. 21 (2016). doi:10.3390/molecules21060685. 
[23] J. Malda, J. Visser, F.P. Melchels, T. Jüngst, W.E. Hennink, W.J. a Dhert, J. Groll, D.W. 
Hutmacher, 25th anniversary article: Engineering hydrogels for biofabrication., Adv. Mater. 25 
(2013) 5011–28. doi:10.1002/adma.201302042. 
[24] J. Wang, Y. Wei, S. Zhao, Y. Zhou, W. He, Y. Zhang, W. Deng, The analysis of viability for 
mammalian cells treated at different temperatures and its application in cell shipment, (2017) 
1–16. 
[25] V.H.M. Mouser, F.P.W. Melchels, J. Visser, W.J.A. Dhert, D. Gawlitta, J. Malda, Yield stress 
determines bioprintability of hydrogels based on gelatin-methacryloyl and gellan gum for 
cartilage bioprinting., Biofabrication. 8 (2016) 035003. doi:10.1088/1758-5090/8/3/035003. 
[26] K. Nair, M. Gandhi, S. Khalil, K.C. Yan, M. Marcolongo, K. Barbee, W. Sun, Characterization 
of cell viability during bioprinting processes, Biotechnol. J. 4 (2009) 1168–1177. 
doi:10.1002/biot.200900004. 
[27] T. Billiet, E. Gevaert, T. De Schryver, M. Cornelissen, P. Dubruel, The 3D printing of gelatin 
methacrylamide cell-laden tissue-engineered constructs with high cell viability., Biomaterials. 
35 (2014) 49–62. doi:10.1016/j.biomaterials.2013.09.078. 
[28] W. Liu, M.A. Heinrich, Y. Zhou, A. Akpek, N. Hu, X. Liu, X. Guan, Z. Zhong, X. Jin, A. 
Khademhosseini, Y.S. Zhang, Extrusion Bioprinting of Shear-Thinning Gelatin Methacryloyl 
Bioinks, Adv. Healthc. Mater. 6 (2017) 1–11. doi:10.1002/adhm.201601451. 
[29] Z. Liu, H. Chen, H. Yang, J. Liang, X. Li, Low-dose UVA radiation-induced adaptive response 
in cultured human dermal fibroblasts, Int. J. Photoenergy. 2012 (2012). 
doi:10.1155/2012/167425. 
[30] T. Vermonden, N.E. Fedorovich, D. van Geemen, J. Alblas, C.F. van Nostrum, W.J.A. Dhert, 
W.E. Hennink, Photopolymerized thermosensitive hydrogels: Synthesis, degradation, and 
cytocompatibility, Biomacromolecules. 9 (2008) 919–926. doi:10.1021/bm7013075. 
[31] E.E. Coates, C.N. Riggin, J.P. Fisher, Photocrosslinked alginate with hyaluronic acid 
hydrogels as vehicles for mesenchymal stem cell encapsulation and chondrogenesis., J. 
Biomed. Mater. Res. A. 101 (2013) 1962–70. doi:10.1002/jbm.a.34499. 
[32] I. Mironi-Harpaz, D.Y. Wang, S. Venkatraman, D. Seliktar, Photopolymerization of cell-
encapsulating hydrogels: Crosslinking efficiency versus cytotoxicity, Acta Biomater. 8 (2012) 
1838–1848. doi:10.1016/j.actbio.2011.12.034. 
[33] A.D. Rouillard, C.M. Berglund, J.Y. Lee, W.J. Polacheck, Y. Tsui, L.J. Bonassar, B.J. Kirby, 
Methods for photocrosslinking alginate hydrogel scaffolds with high cell viability, Tissue Eng. 
- Part C Methods. 17 (2011) 173–179. doi:10.1089/ten.tec.2009.0582. 
[34] M. Ulrich-Vinther, M.D. Maloney, J.J. Goater, K. Søballe, M.B. Goldring, R.J. O’Keefe, E.M. 
Schwarz, Light-activated gene transduction enhances adeno-associated virus vector–
mediated gene expression in human articular chondrocytes, Arthritis Rheum. 46 (2002) 2095–
2104. doi:10.1002/art.10433. 
[35] T.R. Dunkern, G. Fritz, B. Kaina, Ultraviolet light-induced DNA damage triggers apoptosis in 
nucleotide excision repair-de ® cient cells via Bcl-2 decline and caspase-3 / -8 activation, 
(2001) 6026–6038. 
[36]  a. Kinner, W. Wu, C. Staudt, G. Iliakis,  -H2AX in recognition and signaling of DNA double-
strand breaks in the context of chromatin, Nucleic Acids Res. 36 (2008) 5678–5694. 
doi:10.1093/nar/gkn550. 
[37] J. Rouwkema, B.F.J.M. Koopman, C.A.V. Blitterswijk, W.J.A. Dhert, J. Malda, Supply of 
nutrients to cells in engineered tissues, Biotechnol. Genet. Eng. Rev. 26 (2009) 163–178. 
doi:10.5661/bger-26-163. 
[38] S. Ashraf, B.H. Cha, J.S. Kim, J. Ahn, I. Han, H. Park, S.H. Lee, Regulation of senescence 
associated signaling mechanisms in chondrocytes for cartilage tissue regeneration, 
Osteoarthr. Cartil. 24 (2016) 196–205. doi:10.1016/j.joca.2015.07.008. 
[39] S. Kobayashi, A. Meir, J. Urban, Effect of cell density on the rate of glycosaminoglycan 
accumulation by disc and cartilage cells in vitro, J. Orthop. Res. 26 (2008) 493–503. 
doi:10.1002/jor.20507. 
[40] A.R. Gannon, T. Nagel, A.P. Bell, N.C. Avery, D.J. Kelly, Postnatal changes to the mechanical 
properties of articular cartilage are driven by the evolution of its Collagen network, Eur. Cells 
Mater. 29 (2015) 105–123. doi:10.22203/eCM.v029a09. 
[41] J.P. Caffrey, M. , Anton M. Kushnaryov, V. , Marsha S. Reuther, R.L.S. W. Wong, Kristen K. 
Briggs,, Koichi Masuda,  and D. Watson, Flexural Properties of Native and Tissue Engineered 
Human Septal Cartilage, Otolaryngol Head Neck Surg. 4 (2013) 576–581. 
doi:10.1126/scisignal.2001449.Engineering. 
[42] M.F. Griffin, Y. Premakumar, A.M. Seifalian, M. Szarko, P.E.M. Butler, Biomechanical 
characterisation of the human nasal cartilages; implications for tissue engineering, J. Mater. 
Sci. Mater. Med. 27 (2016) 1–6. doi:10.1007/s10856-015-5619-8. 
[43] X. Hu, L. Ma, C. Wang, C. Gao, Gelatin hydrogel prepared by photo-initiated polymerization 
and loaded with TGF-β1 for cartilage tissue engineering, Macromol. Biosci. 9 (2009) 1194–
1201. doi:10.1002/mabi.200900275. 
[44] J. Visser, D. Gawlitta, K.E.M. Benders, S.M.H. Toma, B. Pouran, P.R. van Weeren, W.J.A. 
Dhert, J. Malda, Endochondral bone formation in gelatin methacrylamide hydrogel with 
embedded cartilage-derived matrix particles, Biomaterials. 37 (2015) 174–182. 
doi:10.1016/j.biomaterials.2014.10.020. 
[45] X. Li, S. Chen, J. Li, X. Wang, J. Zhang, N. Kawazoe, G. Chen, 3D Culture of Chondrocytes 
in Gelatin Hydrogels with Different Stiffness, Polym. . 8 (2016). doi:10.3390/polym8080269. 
 
